The company says the Bloom platform helps patients prepare for breast cancer surgery and reconstruction by using supraphysiological preconditioning. This technique intermittently heats the skin causing the release of heat-shock proteins that cause vasodilation and increased blood flow to the area.
According to Plexāā, this technique has been shown to reduce wound healing complications in proof-of-concept clinical trials.
Bloom is being trialed at Stanford University Hospital in California and plans for a market launch in the U.S. in spring 2025.
The collaboration is expected to accelerate the production and scaling of the company’s technology.
“Partnering with Panasonic Manufacturing UK marks a crucial milestone for us. Their renowned expertise in manufacturing excellence and commitment to green manufacturing will enable us to efficiently bring the device to market and scale up globally in-line with demand,” Plexāā founder Saahil Mehta said in a news release.
